Pitango International Mc 2019 Ltd.
Pitango is Israel's premier venture capital firm, managing over $3B in committed capital across early-stage, growth & healthtech funds.
In the firm's own words, from its website.
30 additional team members, 11 additional co-investors and affiliates, 10 additional investments, funds and LPs, 6 events, 2 verified contacts (1 published business email, 1 firm phone)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 3 dealswith MPM Bioimpact
Invests most often alongside MPM Bioimpact (3 shared deals) and 7wire Management (2 shared deals). 3 of the 9 most frequent co-investors were first seen with it on record in the last 12 months.
pair last observed on record 7 Jul 2014, not a deal date · The firms it syndicates with are the likeliest to see the same deals and to fill out its rounds.
Measuredshared rounds and portfolio companies on recordFor Founders building a round, co-investorsCo-investors →
People to know
View all people- Managing Partner | HealthTechWhy: Managing partner: runs the firmNo route on file yet
- Managing DirectorWhy: Managing directorNo route on file yet
- Managing Director Fund Ii, L.P.Why: Managing directorNo route on file yet
Relationship network
55 connected entities4 observed rounds1 repeat counterpartyrounds 2009 to 2026
From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.
Some relationships on this record are counted rather than named here. They open with the full profile.
Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.
- Sponsor
- Company
- Capital provider
- Fund or vehicle
- Person
›How strength and recency are read
Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.
Darker lines were active in the last 24 months or are current; lighter lines are older or undated.
How am I connected?
Name your firm, a company or a person, and DFX finds the published routes to Pitango International Mc 2019 Ltd.: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.
See how you connect to Pitango International Mc 2019 Ltd.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Investing
7 companies on record, 0 new in 12 months
Investments on record
What these amounts mean“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.Acquired, Public, Exited and Active are what the firm’s own portfolio card says, read on the date shown when you hover the chip; they are not deal dates. A company with no chip is one whose card states no outcome: DFX does not assume it is active.| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| No matches found. | portfolio listing | unknown | unknown | unknown | unknown | Sep 14, 2026 | Fact Firm website |
| Altesa BioSciences, Inc. | Form D equity offering | unknown · board | Dr. Seth A. Rudnick (strongly supported) | $75.0M form d sold | unknown | Feb 23, 2026 | Inference Form D |
| Vaxinnate Corp | Form D equity offering | unknown · board | Dr. Seth A. Rudnick (strongly supported) | $15.0M form d sold | unknown | May 19, 2009 | Inference Form D |
Stated thesis versus observed behaviour
- Sectors
- ai, healthcare, quantum
- Stages
- seed
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Team
35 current, 3 departed
Decision makers
- Hila Karah · Managing Partner | HealthTechWhy this person: Managing partner: runs the firm; Named with investment responsibility
- Aaron Mankovski · Managing DirectorWhy this person: Managing director; Named with investment responsibility
- Ayal Itzkovitz · Managing Director Fund Ii, L.P.Why this person: Managing director; Named with investment responsibility
Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.
Investment team
How the team is orderedPartners who lead rounds first (rounds led, then deals attributed, then seniority), then the rest of the investment team, then investor relations, finance and operations. A person named by two sources under two spellings is shown once.- Managing Partner | HealthTech
- Managing Director
- Managing Director Fund Ii, L.P.
Contacts
1 published business email, 1 firm phone on record, each with its source. Values open with the complete profile.
Funds and LPs
8 vehicles, 1 LPs disclosed
Funds and vehicles
What these amounts meanGAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Pitango Co-Investor Spv No. 5 (dn), L.P. | SPV or co-invest vehicle | 2022 adv first reported | Active deployment | $102M Mar 31, 2026 | 11 | $0 | Jan 12, 2021 |
| Pitango Co-Investor Spv No. 4 (gc), L.P. | SPV or co-invest vehicle | 2022 adv first reported | Active deployment | $8.8M Mar 28, 2024 | 2 | $0 | Jan 12, 2021 |
| Pitango Viii Supplemental (F.E) L.P. | Fund | 2022 adv first reported | Active deployment | $3.5M Mar 31, 2026 | 1 | unknown | unknown |
Limited partners
- 2020-07-292 commitments to 2 funds · $20.0M disclosed
Known LPs and allocators
What these amounts and dates areEach commitment is counted once across the pension tape and the allocator graph. A commitment date prints only when the source printed one; otherwise the row carries the report date. A foundation’s 990-PF line is a holding at fair value, never a commitment. Rows without a fund on the venture graph are commitments to this manager.| Allocator | Type | Fund | Amount | Date | Source |
|---|---|---|---|---|---|
| New York State Common Retirement Fund | PUBLIC INSTITUTIONAL POOL | Pitango Venture Capital Fund Viii, L.P. | $10.0M committed | reported as of Mar 31, 2025 | Fact Pension disclosure |
| New York State Common Retirement Fund | PUBLIC INSTITUTIONAL POOL | Pitango Growth Fund II, L.P. | $10.0M committed | reported as of Mar 31, 2025 | Fact Pension disclosure |
| Leona M & Harry B Helmsley Charitable Trust | FOUNDATION | PITANGO GROWTH II at Pitango International Mc 2019 Ltd. | $22.2M fair value on the foundation's return | reported as of Mar 31, 2025 | Fact IRS Form 990 / 990-PF e-file returns |
Relationships across DFX
9 co-investors · on 1 other DFX graph
Co-investors
- 2014-07-073 shared deals · recurring
- 2026-09-162 shared deals · recurring
- 2014-07-072 shared deals · recurring
Compare portfolios with MPM Bioimpact, 7wire Management, LLC, Onset Ventures or any firm. Co-investors across the market
Across DFX and the capital chainon 1 other DFX graph · 12 capital paths ShowHide
- The same institution is held on Allocators, matched by identifier. See which records
Pitango International Mc 2019 Ltd. is the same institution as 1 record in Allocators.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Pitango International Mc 2019 Ltd. sits on 12 traced paths of capital across the graphs.
DFX traced 12 paths of capital through this record
Every record on each path, what it committed or lent, and as of when.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.
Checking your plan…
Evidence and history
11 dated events, 45 observations from 3 sources
Timeline
- Mar 31, 2026Pitango Co Investor Spv (F.O), Limited Partnership first reported on Form ADV by Pitango International Mc 2019 Ltd. (Venture Capital Fund), GAV $3,506,000Fund first reported on Form ADVFundsInferencePitango Co Investor Spv (F.O), Limited PartnershipForm ADV
- Mar 30, 2022Pitango Co-Investor Spv No. 4 (gc), L.P. first reported on Form ADV by Pitango International Mc 2019 Ltd. (Venture Capital Fund), GAV $9,000,000
- Mar 30, 2022Pitango Co-Investor Spv No. 5 (dn), L.P. first reported on Form ADV by Pitango International Mc 2019 Ltd. (Venture Capital Fund), GAV $28,403,000
- Mar 30, 2022Pitango Venture Capital Fund Viii - Israel L.P. no longer reported on Form ADV by Pitango International Mc 2019 Ltd.
- Mar 30, 2022Pitango Viii Supplemental (F.E) L.P. first reported on Form ADV by Pitango International Mc 2019 Ltd. (Venture Capital Fund), GAV $1,996,000
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Mar 31, 2026 · 7 private fundsShowHide
- Headquarters
- Herzliya, Israeladviserinfo.sec.gov
- Office address
- unknownadviserinfo.sec.gov
- Business phone
- unknownadviserinfo.sec.gov
- Website
- PITANGO.COM
- SEC adviser type
- Exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- Private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- Mar 31, 2026
- Private funds reported
- 7 (7 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets, adviser total
- $736Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- A.Y.M Ventures 2004 Ltd. (Shareholder), owns 10% to 25%; ROM Ventures Investments 2004 Ltd. (Shareholder), owns 10% to 25%; L.M. Eyal Niv Ltd. (Shareholder), owns 10% to 25%
Classification history
Classification history
Every classification this record has carried4 on recordShowHide
- Sep 23, 2026Multi-stage venture firm (probable, 80%)Both early and growth/opportunity families, reported GAV $745M
- Sep 15, 2026Multi-stage venture firm (probable, 80%)Both early and growth/opportunity families, reported GAV $857M
- Sep 14, 2026Multi-stage venture firm (probable, 80%)Both early and growth/opportunity families, reported GAV $853M
- Sep 12, 2026Multi-stage venture firm (probable, 80%)Both early and growth/opportunity families, reported GAV $857M
Evidence
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| SEC exemption claimed | Private fund adviser | Mar 28, 2024 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 31, 2026 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 28, 2024 | Fact | Form ADV |
| First Form ADV filing | 2021-03-26 | Mar 31, 2026 | Fact | Form ADV |
| First Form ADV filing | 2021-03-26 | Mar 28, 2024 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-30 | Oct 1, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-29 | Sep 30, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-25 | Sep 26, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-23 | Sep 24, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-21 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-22 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1 | Sep 12, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-03-31 | Mar 31, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2024-03-28 | Mar 28, 2024 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 31, 2026 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 28, 2024 | Fact | Form ADV |
| Business phone | Mar 28, 2024 | Fact | Form ADV | |
| Contact page url | Sep 30, 2026 | Fact | ||
| Contact page url | Sep 16, 2026 | Fact | ||
| Description | Sep 30, 2026 | Fact | ||
| Headquarters | Mar 28, 2024 | Fact | Form ADV | |
| Office address | Mar 28, 2024 | Fact | Form ADV | |
| Self-described type | Venture capital | Sep 30, 2026 | Fact | |
| Self-described type | Venture capital | Sep 16, 2026 | Fact | |
| Self-described type | Venture capital | Sep 14, 2026 | Fact | |
| Legal form | Corporation | Mar 28, 2024 | Fact | Form ADV |
| Portfolio page | Sep 30, 2026 | Fact | ||
| Portfolio page | Sep 16, 2026 | Fact | ||
| Portfolio page | Sep 14, 2026 | Fact | ||
| Private funds reported | 7 | Mar 31, 2026 | Fact | Form ADV |
| Private funds reported | 7 | Mar 28, 2024 | Fact | Form ADV |
| Private fund gross assets (reported) | $736M | Mar 31, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $857M | Mar 28, 2024 | Fact | Form ADV |
| Schedule a diff | sadiff-1 | Mar 31, 2026 | Fact | Form ADV |
| Stated sectors | AI, healthcare, quantum “sector words on the home page” | Sep 30, 2026 | Fact | |
| Stated sectors | AI, healthcare, quantum “sector words on the home page” | Sep 16, 2026 | Fact | |
| Stated sectors | AI, healthcare, quantum “sector words on the home page” | Sep 14, 2026 | Fact | |
| Stated stages | seed “stage words on the home page” | Sep 30, 2026 | Fact | |
| Stated stages | seed “stage words on the home page” | Sep 16, 2026 | Fact | |
| Stated stages | seed “stage words on the home page” | Sep 14, 2026 | Fact | |
| Team page | Sep 30, 2026 | Fact | ||
| Team page | Sep 16, 2026 | Fact | ||
| Team page | Sep 14, 2026 | Fact | ||
| Venture funds reported | 7 | Mar 31, 2026 | Fact | Form ADV |
| Venture funds reported | 7 | Mar 28, 2024 | Fact | Form ADV |
| Website | Mar 28, 2024 | Fact | Form ADV | |
| Site title | Sep 30, 2026 | Fact | ||
| Site title | Sep 16, 2026 | Fact | ||
| Site title | Sep 14, 2026 | Fact |
How this is scored
Scores, classification basis and filing advisersMulti-stage venture firm, probable · 5 filing advisers share this firmShowHide
Both early and growth/opportunity families, reported GAV $745M
This firm files as 5 advisers on pitango.com: Pitango Healthtech, Pitango Healthtech Mc 2022 Ltd, Pitango Venture Capital and 1 more adviser. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
- importance
- gav: 0.57 · funds: 0.75 · people: 1 · investments: 0.26 · co investors: 0.39
- active deployment
- investments 12m: 0.13 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 0 · latest investment at: 2026-02-19
- emerging manager
- fund count: 9 · reported gav: $736M · first adv filing: 2021-03-26 · years since first filing: 5.5
Fits, record history and connections
scored matches for this investor, every identity change, every edge
Record history
- Adviser's first ADV filing2021-03-26source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.